BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 25779561)

  • 1. Right to try?
    Lieu CH; Sorkin A; Messersmith WA
    J Clin Oncol; 2015 May; 33(13):1518. PubMed ID: 25779561
    [No Abstract]   [Full Text] [Related]  

  • 2. False hope with the Right to Try Act.
    The Lancet
    Lancet; 2018 Jun; 391(10137):2296. PubMed ID: 29900858
    [No Abstract]   [Full Text] [Related]  

  • 3. US Food and Drug Administration Efforts to Facilitate the Use of Expanded Access Programs.
    Kim T; Lurie P; Pazdur R
    J Clin Oncol; 2015 Nov; 33(33):3979-80. PubMed ID: 26282656
    [No Abstract]   [Full Text] [Related]  

  • 4. Individual patient treatment use of unapproved drugs: a new option for the seriously ill.
    Simon LS; Green A
    J Pain Palliat Care Pharmacother; 2010 Mar; 24(1):19-22. PubMed ID: 20345195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study in futility: Abigail Alliance for Better Access to Developmental Drugs will not expand access to experimental drugs for the terminally ill.
    Ochs A
    Seton Hall Law Rev; 2009; 39(2):559-603. PubMed ID: 19462540
    [No Abstract]   [Full Text] [Related]  

  • 6. The Right to Try: An Overview of Efforts to Obtain Expedited Access to Unapproved Treatment for the Terminally Ill.
    Tsakopoulos A; Han J; Nodler H; Russo V
    Food Drug Law J; 2015; 70(4):617-41. PubMed ID: 26827394
    [No Abstract]   [Full Text] [Related]  

  • 7. Should terminally ill patients have access to phase I drugs?
    Bristol N
    Lancet; 2007 Mar; 369(9564):815-6. PubMed ID: 17366691
    [No Abstract]   [Full Text] [Related]  

  • 8. Minnesota's Right to Try law.
    Hermer LD
    Minn Med; 2016; 99(1):30-2. PubMed ID: 26897894
    [No Abstract]   [Full Text] [Related]  

  • 9. Access to Investigational Drugs: FDA Expanded Access Programs or "Right-to-Try" Legislation?
    Holbein ME; Berglund JP; Weatherwax K; Gerber DE; Adamo JE
    Clin Transl Sci; 2015 Oct; 8(5):526-32. PubMed ID: 25588691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental drugs on trial.
    Benderly BL
    Sci Am; 2007 Oct; 297(4):92-9. PubMed ID: 17926760
    [No Abstract]   [Full Text] [Related]  

  • 11. Why are promising new drugs for dying patients still out of reach?
    Peckham C
    MedGenMed; 2007 Jun; 9(2):49. PubMed ID: 17955104
    [No Abstract]   [Full Text] [Related]  

  • 12. Federal Right-to-Try Legislation - Threatening the FDA's Public Health Mission.
    Joffe S; Lynch HF
    N Engl J Med; 2018 Feb; 378(8):695-697. PubMed ID: 29320302
    [No Abstract]   [Full Text] [Related]  

  • 13. Patient advocacy. 'Right to Try' laws bypass FDA for last-ditch treatments.
    Servick K
    Science; 2014 Jun; 344(6190):1329. PubMed ID: 24948714
    [No Abstract]   [Full Text] [Related]  

  • 14. The proper focus for FDA regulations: why the fundamental right to self-preservation should allow terminally ill patients with no treatment options to attempt to save their lives.
    Puckett A
    SMU Law Rev; 2007; 60(2):635-65. PubMed ID: 17849632
    [No Abstract]   [Full Text] [Related]  

  • 15. "Right to Try" Laws: The Gap between Experts and Advocates.
    Dresser R
    Hastings Cent Rep; 2015; 45(3):9-10. PubMed ID: 25944200
    [No Abstract]   [Full Text] [Related]  

  • 16. Constitutional law--substantive due process--en banc D.C. Circuit rejects fundamental right to experimental medications.--Abigail Alliance for Better Access to Developmental Drugs v. von Eschenbach, 495 F.3d 695 (D.C. Cir. 2007)(en banc), cert. denied, 128 S. Ct. 1069 (2008).
    Harv Law Rev; 2008 Apr; 121(6):1685-92. PubMed ID: 18524069
    [No Abstract]   [Full Text] [Related]  

  • 17. Practical, legal, and ethical issues in expanded access to investigational drugs.
    Darrow JJ; Sarpatwari A; Avorn J; Kesselheim AS
    N Engl J Med; 2015 Jan; 372(3):279-86. PubMed ID: 25587952
    [No Abstract]   [Full Text] [Related]  

  • 18. Right to experimental treatment: FDA new drug approval, constitutional rights, and the public's health.
    Leonard EW
    J Law Med Ethics; 2009; 37(2):269-79. PubMed ID: 19493072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Access to clinical devices through nontraditional routes.
    Klepinski RJ
    Food Drug Law J; 2007; 62(4):849-63. PubMed ID: 18557233
    [No Abstract]   [Full Text] [Related]  

  • 20. Why doctors should worry about preemption.
    Curfman GD; Morrissey S; Drazen JM
    N Engl J Med; 2008 Jul; 359(1):1-3. PubMed ID: 18596269
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.